Cannabis products have become increasingly diverse in Europe and close monitoring of their potency and potential health effects is essential. These are among the conclusions of a new report published today by the EU drugs agency (EMCDDA) ahead of International day against drug abuse and illicit trafficking (26 June). The report — Developments in the European cannabis market — provides an overview of emerging and established cannabis products in Europe.
Related: